Viewing Study NCT00447512



Ignite Creation Date: 2024-05-05 @ 5:24 PM
Last Modification Date: 2024-10-26 @ 9:31 AM
Study NCT ID: NCT00447512
Status: COMPLETED
Last Update Posted: 2007-10-31
First Post: 2007-03-13

Brief Title: Effects of Ghrelin on the Sleep-EEG and Nocturnal Secretion of Hormones
Sponsor: Max-Planck-Institute of Psychiatry
Organization: Max-Planck-Institute of Psychiatry

Study Overview

Official Title: Effects of Ghrelin on the Sleep-EEG and Nocturnal Secretion of Hormones
Status: COMPLETED
Status Verified Date: 2007-10
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Ghrelin an acylated peptide consisting of 28 amino acids is the endogenous ligand of the growth hormone secretagogue receptor GHS-R It is synthesized predominantly in the stomach but has been also identified in a variety of other organs Alike a wide range of central and peripheral endocrine and non-endocrine actions has been described e g being a releasing factor of growth hormone prolactin and ACTH a modulator of cell proliferation and apoptosis a regulator of sleep-wake regulation and a orexigenic hormone Aims of this study are

A To determine the effect of exogenous ghrelin on sleep-EEG variables and hormones of the hypothalamic-pituitary-adrenocortical HPA axis the gonadotropic axis and the hypothalamic-pituitary-gonadal axis in healthy subjects of both genders age groups 20-30 35-45 60-70 years

B To determine the effect of exogenous ghrelin on sleep-EEG variables and hormones of the HPA axis the gonadotropic axis and the hypothalamic-pituitary-gonadal axis in patients with major depression age range 20-65 years
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None